73 related articles for article (PubMed ID: 3174725)
1. A new suspension form of smectite (Liquid 'Diasorb') for the treatment of acute diarrhoea: a randomized comparative study.
Leber W
Pharmatherapeutica; 1988; 5(4):256-60. PubMed ID: 3174725
[TBL] [Abstract][Full Text] [Related]
2. Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea.
Kuge T; Shibata T; Willett MS
Clin Ther; 2004 Oct; 26(10):1644-51. PubMed ID: 15598481
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: Smectite in the treatment of acute infectious diarrhoea in children.
Szajewska H; Dziechciarz P; Mrukowicz J
Aliment Pharmacol Ther; 2006 Jan; 23(2):217-27. PubMed ID: 16393300
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy of smectite in acute infantile diarrhea, compared to a placebo and loperamide].
Gilbert B; Lienhardt A; Palomera S; Barberis L; Borreda D
Ann Pediatr (Paris); 1991 Nov; 38(9):633-6. PubMed ID: 1750747
[TBL] [Abstract][Full Text] [Related]
5. Loperamide oxide in the treatment of acute diarrhea in adults.
Dettmer A
Clin Ther; 1994; 16(6):972-80. PubMed ID: 7697694
[TBL] [Abstract][Full Text] [Related]
6. Control randomized study of rehydration/rehydration with dioctahedral smectite in ambulatory Thai infants with acute diarrhea.
Lexomboon U; Harikul S; Lortholary O
Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):157-62. PubMed ID: 7825006
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of dioctahedral smectite in treating patients of diarrhea-predominant irritable bowel syndrome.
Chang FY; Lu CL; Chen CY; Luo JC
J Gastroenterol Hepatol; 2007 Dec; 22(12):2266-72. PubMed ID: 17559369
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
9. [Therapy trends in the prevention of radiation-induced diarrhea after pelvic and abdominal irradiation. Results of a tricenter study].
Hombrink J; Voss AC; Fröhlich D; Glatzel M; Krauss A; Glaser FH
Strahlenther Onkol; 1995 Jan; 171(1):49-53. PubMed ID: 7839305
[TBL] [Abstract][Full Text] [Related]
10. Treatment of travellers' diarrhoea: zaldaride compared with loperamide and placebo.
Silberschmidt G; Schick MT; Steffen R; Kilpatrick ME; Murphy JR; Oyofo BA; el-Etr S; Gyurech D; Mourad AS; Mathewson JT
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):871-5. PubMed ID: 8574720
[TBL] [Abstract][Full Text] [Related]
11. Azithromycin and loperamide are comparable to levofloxacin and loperamide for the treatment of traveler's diarrhea in United States military personnel in Turkey.
Sanders JW; Frenck RW; Putnam SD; Riddle MS; Johnston JR; Ulukan S; Rockabrand DM; Monteville MR; Tribble DR
Clin Infect Dis; 2007 Aug; 45(3):294-301. PubMed ID: 18688944
[TBL] [Abstract][Full Text] [Related]
12. First-line treatment in acute non-dysenteric diarrhoea: clinical comparison of loperamide oxide, loperamide and placebo. UK Janssen Research Group of General Practitioners.
Hughes IW
Br J Clin Pract; 1995; 49(4):181-5. PubMed ID: 7547157
[TBL] [Abstract][Full Text] [Related]
13. Loperamide in the symptomatic control of chronic diarrhoea. Double-blind placebo-controlled study.
Tijtgat GN; Meuwissen SG; Huibregtse K
Ann Clin Res; 1975 Oct; 7(5):325-30. PubMed ID: 1108754
[TBL] [Abstract][Full Text] [Related]
14. Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.
Mystakidou K; Katsouda E; Tsilika E; Smyrniotis V; Vassiliou I; Tsiatas M; Vlahos L
Anticancer Res; 2006; 26(3B):2325-8. PubMed ID: 16821610
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of diosmectite in acute diarrhea in children].
Milocco C; Bolis A; Rizzo V; Suprani T; Cerasoli G; Marani M; Pocecco M
Pediatr Med Chir; 1999; 21(3):129-33. PubMed ID: 10687162
[TBL] [Abstract][Full Text] [Related]
16. Di-tri-octahedral smectite for the prevention of post-operative diarrhea in equids with surgical disease of the large intestine: results of a randomized clinical trial.
Hassel DM; Smith PA; Nieto JE; Beldomenico P; Spier SJ
Vet J; 2009 Nov; 182(2):210-4. PubMed ID: 19097815
[TBL] [Abstract][Full Text] [Related]
17. Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea.
Dupont C; Foo JL; Garnier P; Moore N; Mathiex-Fortunet H; Salazar-Lindo E;
Clin Gastroenterol Hepatol; 2009 Apr; 7(4):456-62. PubMed ID: 19268266
[TBL] [Abstract][Full Text] [Related]
18. Oral rehydration therapy plus loperamide versus loperamide alone in the treatment of traveler's diarrhea.
Caeiro JP; DuPont HL; Albrecht H; Ericsson CD
Clin Infect Dis; 1999 Jun; 28(6):1286-9. PubMed ID: 10451167
[TBL] [Abstract][Full Text] [Related]
19. A multicenter double-blind controlled trial comparing lidamidine HCl and loperamide in the symptomatic treatment of acute diarrhoea.
Gasbarrini G; Corazza GR; Feliciani M; Albano O; Stufano N; Altomare E; Fontana G; Valpiani D; Chiodo F; Banterle C
Arzneimittelforschung; 1986 Dec; 36(12):1843-5. PubMed ID: 3551969
[TBL] [Abstract][Full Text] [Related]
20. Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.
Ericsson CD; DuPont HL; Okhuysen PC; Jiang ZD; DuPont MW
J Travel Med; 2007; 14(5):312-9. PubMed ID: 17883462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
